Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 15 de 15
Filter
1.
NCHS Data Brief ; (469): 1-8, 2023 Jun.
Article in English | MEDLINE | ID: mdl-37314338

ABSTRACT

With the disruptions to access and use of care caused by the COVID-19 pandemic, emergency department (ED) visit rates decreased from 2019 to 2020 among children and adolescents (1). The ED visit rate for children under age 1 year in 2020 was nearly one-half of the rate in 2019, and the rate for those aged 1-17 years decreased over the same period (2). This report uses data from the National Hospital Ambulatory Medical Care Survey (NHAMCS) (3,4) to compare ED visits for children aged 0-17 from 2019 to 2020, by age group, sex, and race and ethnicity, and to assess changes in wait time at ED visits.


Subject(s)
COVID-19 , Adolescent , United States/epidemiology , Humans , Child , COVID-19/epidemiology , Pandemics , Emergency Service, Hospital , Ethnicity
2.
Natl Health Stat Report ; (181): 1-9, 2023 03.
Article in English | MEDLINE | ID: mdl-36939656

ABSTRACT

Objective-This report describes emergency department (ED) visits related to mental health disorders among adults and assesses differences in mental health-related ED visit characteristics by race and Hispanic ethnicity.


Subject(s)
Ethnicity , Mental Disorders , Adult , Humans , United States/epidemiology , Mental Health , Mental Disorders/epidemiology , Hispanic or Latino , Emergency Service, Hospital
3.
Natl Health Stat Report ; (175): 1-7, 2022 09.
Article in English | MEDLINE | ID: mdl-36190441

ABSTRACT

Objective-To assess final estimates of physician experiences related to COVID-19 and to compare preliminary estimates used in NCHS early-release dashboards with final estimates in this report.


Subject(s)
COVID-19 , Physicians , Humans , Pandemics , Physicians' Offices , United States/epidemiology
4.
Natl Health Stat Report ; (167): 1-9, 2022 01.
Article in English | MEDLINE | ID: mdl-35089854

ABSTRACT

Objective-This report demonstrates the ability of data from the National Hospital Care Survey (NHCS) linked to the National Death Index (NDI) to provide information on inpatient hospitalizations and in-hospital and post-acute mortality among patients hospitalized for a specific condition, in this case pneumonia.


Subject(s)
Inpatients , Pneumonia , Emergency Service, Hospital , Health Care Surveys , Hospitalization , Hospitals , Humans , Pneumonia/diagnosis , United States/epidemiology
5.
Fam Syst Health ; 39(1): 66-76, 2021 Mar.
Article in English | MEDLINE | ID: mdl-34014731

ABSTRACT

INTRODUCTION: Transforming administrative health care data into meaningful metrics has been critical to the implementation of the Department of Defense's Primary Care Behavioral Health (PCBH) program. METHODS: Data from clinical encounters with PCBH providers are used to develop metrics of program performance collaboratively. Metrics focus on describing the PCBH program and patients, provider fidelity to the model, and provider performance. These metrics form two key deliverables: a monitoring dashboard for program managers and a training dashboard for expert trainers conducting site visits. RESULTS: Behavioral health consultants (BHCs) conducted nearly 200,000 encounters with more than 100,000 unique patients in fiscal year 2019 at more than 170 locations in 6 countries and 37 states. Administrative data derived from these encounters were used to create a variety of metrics that describe practice and performance at both the provider and program levels. These metrics are delivered through a variety of analytic products to stakeholders who use that information to make data-driven decisions about program direction and provider training. DISCUSSION: We discuss examples of program management decisions and expert trainer actions based on these dashboards, highlighting the benefits of continued collaboration between analysts and program managers. Specifically, excerpts from several dashboards illustrate how penetration and productivity metrics yield specific, tailored action plans to improve care delivery and provider performance. (PsycInfo Database Record (c) 2021 APA, all rights reserved).


Subject(s)
Data Science/methods , Delivery of Health Care/methods , Mental Health Services/statistics & numerical data , Adolescent , Adult , Aged , Child , Child, Preschool , Data Science/statistics & numerical data , Delivery of Health Care/statistics & numerical data , Delivery of Health Care, Integrated/methods , Delivery of Health Care, Integrated/statistics & numerical data , Female , Humans , Infant , Informatics/instrumentation , Informatics/methods , Male , Middle Aged , Primary Health Care/methods , Primary Health Care/statistics & numerical data , United States , United States Department of Defense
6.
Subst Abus ; 42(4): 638-645, 2021.
Article in English | MEDLINE | ID: mdl-32870103

ABSTRACT

Background: Alcohol-use disorders (AUD) pose a significant challenge for the United States (US) military. The US Department of Defense has strongly recommended several medications for use in the treatment of patients with diagnosed AUD. This study assessed the prescription of medications for active duty service members (ADSMs) diagnosed with AUD in the US Military Health System (MHS). Methods: Rates of prescription orders were retrospectively examined from 2010 to 2017 among ADSMs with an incident diagnosis of moderate-to-severe AUD. The rate of prescription orders was defined as the proportion of ADSMs with an ICD-9 or ICD-10 diagnosis code of alcohol dependence who received an order for acamprosate, disulfiram, naltrexone, and/or topiramate at a military treatment facility in the year following their incident diagnosis. Results: ADSMs receiving an order for at least one medication in the year following their incident AUD diagnosis increased from 8.8% in 2010 to 16.2% in 2017 (RR = 1.84, 95% CI, 1.76, 1.93). Oral naltrexone was ordered most frequently among this patient population, while injectable naltrexone, a medication option meant to ease and improve adherence, was ordered for a smaller proportion of patients. Conclusions: Most ADSMs who might benefit from prescriptions for AUD are not receiving them as part of their treatment despite strong clinical evidence and Department of Defense policy support for their use among this cohort.


Subject(s)
Alcohol Deterrents , Alcoholism , Acamprosate/therapeutic use , Alcohol Deterrents/therapeutic use , Alcoholism/drug therapy , Alcoholism/epidemiology , Humans , Naltrexone/therapeutic use , Prescriptions , Retrospective Studies , United States
7.
NCHS Data Brief ; (426): 1-8, 2021 Dec.
Article in English | MEDLINE | ID: mdl-34982662

ABSTRACT

Mental health disorders, which include mental illnesses and substance use disorders, are a group of conditions characterized by alterations in thinking, emotions, or behavior (1). In 2019, 61.2 million adults aged 18 and over in the United States had a mental health disorder in the past year (2). This report presents data on emergency department (ED) visits by adults with mental health disorders.


Subject(s)
Mental Disorders , Substance-Related Disorders , Adolescent , Adult , Emergency Service, Hospital , Humans , Mental Disorders/epidemiology , Mental Health , Substance-Related Disorders/epidemiology , United States/epidemiology
8.
Clin Neuropsychol ; 34(6): 1124-1133, 2020 08.
Article in English | MEDLINE | ID: mdl-31985330

ABSTRACT

OBJECTIVE: Prior research indicates that there is an additive association between traumatic brain injury and mental health diagnoses on health-care utilization. This assumed additivity has not been formally assessed. The objective of this study was to estimate additive and multiplicative interactions associated with mild traumatic brain injury (mTBI) and pre-existing health conditions. METHOD: Active-duty military patient records over a nine-year period were sampled within four exposure groups (N = 4500 per group) defined jointly by incident mTBI and pre-existing mental health diagnoses. Outpatient and inpatient health encounters were compared between the four exposure groups using generalized linear models for count and proportion outcomes. Additive interactions were estimated using the interaction contrast ratio. Multiplicative interactions were estimated as a product term in the generalized linear models. RESULTS: The joint association of mTBI and pre-existing mental health diagnoses with health-care utilization, overall, was less than multiplicative and greater than additive. Patients with both exposures experienced more health-care utilization than expected under the assumed additivity (independence) of the two exposures. PTSD and anxiety diagnoses were the MH diagnoses associated with the largest interaction contrast values specific to total outpatient encounters. CONCLUSIONS: Studies of the interaction of two diagnoses on subsequent health-care utilization should examine both additive and multiplicative interactions. The greater-than-additive findings in this study indicate that there may be synergy, for at least some patients, between mTBI injury and mental health that complicates the treatment course.


Subject(s)
Brain Concussion/diagnosis , Military Personnel/psychology , Neuropsychological Tests/standards , Patient Acceptance of Health Care/psychology , Adolescent , Adult , Brain Concussion/psychology , Female , Humans , Male , Retrospective Studies , Young Adult
10.
BMC Health Serv Res ; 19(1): 210, 2019 Apr 02.
Article in English | MEDLINE | ID: mdl-30940149

ABSTRACT

BACKGROUND: Prevention of mother-to-child transmission (PMTCT) across sub-Saharan Africa has rapidly shifted towards Option B+, an approach in which all HIV+ pregnant and breastfeeding women initiate lifelong antiretroviral therapy (ART) independent of CD4+ count. Healthcare workers (HCW) are critical to the success of Option B+, yet little is known regarding HCW acceptability of Option B+, particularly over time. METHODS: Ten health facilities in the Manzini and Lubombo regions of eSwatini transitioned from Option A to Option B+ between 2013 and 2014 as part of the Safe Generations study examining PMTCT retention. Fifty HCWs (5 per facility) completed questionnaires assessing feasibility and acceptability: (1) prior to transitioning to Option B+, (2) two months post transition, and (3) approximately 2 years post Option B+ transition. This analysis describes HCW perceptions and experiences two years after transitioning to Option B+. RESULTS: Two years after transition, 80% of HCWs surveyed reported that Option B+ was easy for HCWs, noting that it was particularly easy to explain and coordinate. Immediate ART initiation also reduced delays by eliminating need for laboratory tests prior to ART initiation. Additionally, HCWs reported ease of patient follow-up (58%), documentation (56%), and counseling (58%) under Option B+. Findings also indicate that a majority of HCWs reported that their workloads increased under Option B+. Sixty-eight percent of HCWs at two years post-transition reported more work under Option B+, specifically noting increased involvement in adherence counseling, prescribing/monitoring medications, and appointment scheduling/tracking. Some HCWs attributed their higher workloads to increased client loads, now that all HIV-positive women were initiated on ART. New barriers to patient uptake, and issues related to retention, adherence, and follow-up were also noted as challenges face by HCW when implementing Option B+. CONCLUSIONS: Overall, HCWs found Option B+ to be acceptable and feasible while providing critical insights into the practical issues of universal ART. Further strengthening of the healthcare system may be necessary to alleviate worker burden and to ensure effective monitoring of client retention and adherence. HCW perceptions and experiences with Option B+ should be considered more broadly as countries implement Option B+ and consider universal treatment for all HIV+ individuals. TRIAL REGISTRATION: http://clinicaltrials.gov NCT01891799 , registered on July 3, 2013.


Subject(s)
Anti-HIV Agents/therapeutic use , HIV Infections/prevention & control , Infectious Disease Transmission, Vertical/prevention & control , Mothers , Patient Acceptance of Health Care/statistics & numerical data , Pregnancy Complications, Infectious/prevention & control , Adult , Breast Feeding/statistics & numerical data , Female , Follow-Up Studies , HIV Infections/drug therapy , Health Personnel , Humans , Infant , Infant, Newborn , Mothers/psychology , Pregnancy , Pregnancy Complications, Infectious/drug therapy
11.
J Int AIDS Soc ; 20(1): 21748, 2017 06 28.
Article in English | MEDLINE | ID: mdl-28691440

ABSTRACT

INTRODUCTION: Decentralization of HIV care for children has been recommended to improve paediatric outcomes by making antiretroviral treatment (ART) more accessible. We documented outcomes of children transferred after initiating ART at a large tertiary hospital in the Eastern Cape of South Africa. METHODS: Electronic medical records for all children 0-15 years initiating ART at Dora Nginza Hospital (DNH) in Port Elizabeth, South Africa January 2004 to September 2015 were examined. Records for children transferred to primary and community clinics were searched at 16 health facilities to identify children with successful (at least one recorded visit) and unsuccessful transfer (no visits). We identified all children lost to follow-up (LTF) after ART initiation: those LTF at DNH (no visit >6 months), children with unsuccessful transfer, and children LTF after successful transfer (no visit >6 months). Community tracing was conducted to locate caregivers of children LTF and electronic laboratory data were searched to measure reengagement in care, including silent transfers. RESULTS: 1,582 children initiated ART at median age of 4 years [interquartile range (IQR): 1-8] and median CD4+ of 278 cells/mm3 [IQR: 119-526]. A total of 901 (57.0%) children were transferred, 644 (71.5%) to study facilities; 433 (67.2%) children had successful transfer and 211 (32.8%) had unsuccessful transfer. In total, 399 children were LTF: 105 (26.3%) from DNH, 211 (52.9%) through unsuccessful transfer and 83 (20.8%) following successful transfer. Community tracing was conducted for 120 (30.1%) of 399 children LTF and 66 (55.0%) caregivers were located and interviewed. Four children had died. Among 62 children still alive, 8 (12.9%) were reported to not be in care or taking ART and 18 (29.0%) were also not taking ART. Overall, 65 (16.3%) of 399 children LTF had a laboratory result within 18 months of their last visit indicating silent transfer and 112 (28.1%) had lab results from 2015 to 2016 indicating current care. CONCLUSION: We found that only two-thirds of children on ART transferred to primary and community health clinics had successful transfer. These findings suggest that transfer is a particularly vulnerable step in the paediatric HIV care cascade.


Subject(s)
Anti-HIV Agents/therapeutic use , HIV Infections/drug therapy , Lost to Follow-Up , Adolescent , Ambulatory Care Facilities , Black People , Child , Child, Preschool , Cohort Studies , Female , Follow-Up Studies , Humans , Infant , Infant, Newborn , Male , Politics , Retrospective Studies , South Africa , Tertiary Care Centers
13.
J Interpers Violence ; 32(1): 49-75, 2017 01.
Article in English | MEDLINE | ID: mdl-25952291

ABSTRACT

Research is just beginning to explore the intersection of bullying and relationship violence. The relationship between these forms of youth aggression has yet to be examined in diverse urban centers, including New York City (NYC). This study seeks to identify intersections of joint victimization from bullying and electronic bullying (e-bullying) with physical relationship violence (pRV). This study examines data from the NYC Youth Risk Behavior Survey (YRBS), a representative sample of NYC public high school students, to assess the concurrent victimization from bullying at school and e-bullying with pRV, operationalized as physical violence by a dating partner in the past 12 months. Students who reported being bullied at school and e-bullied had increased odds (bullied: OR = 2.5, 95% CI [2.1, 2.9]; e-bullied: OR = 3.0, 95% CI [2.6, 3.5]) of also being victimized by pRV compared with those who did not report being bullied or e-bullied. In logistic regression models, being bullied at school and being e-bullied remained significant predictors of students' odds of reporting pRV (bullied: AOR = 2.6, 95% CI [2.2, 3.1]; e-bullied: AOR = 3.0, 95% CI [2.5, 3.6]) while controlling for race, gender, sexual orientation, and age. This research is the first to assess the intersection of victimization from bullying and e-bullying with pRV in a large, diverse, random sample of urban high school students. In this sample, students who report being bullied or e-bullied are more likely also to report pRV than students who have not been bullied or e-bullied. This research has potential implications for educators, adolescent health and social service providers, and policy makers to tailor programs and enact policies that jointly address bullying and pRV. Future studies are needed to longitudinally assess both victimization from and perpetration of bullying and pRV.


Subject(s)
Bullying/statistics & numerical data , Crime Victims/statistics & numerical data , Intimate Partner Violence/statistics & numerical data , Adolescent , Aggression , Child , Female , Humans , Male , Peer Group , Schools , Students
14.
Prog Community Health Partnersh ; 10(2): 225-33, 2016.
Article in English | MEDLINE | ID: mdl-27346768

ABSTRACT

BACKGROUND: Linkage to community health and social services after incarceration is often inadequate. This is troubling, because risk taking and poor health are common immediately after release, and access to health providers and insurance helps individuals to transition home. OBJECTIVES: This article describes how faculty and clinicians at a large academic health center in New York City, established partnerships with justice programs to jointly develop services that aimed to increase health care access for men in the justice system. METHODS: We describe how faculty and students from Columbia University's Mailman School of Public Health (MSPH), clinicians from New York-Presbyterian Hospital's (NYPH) Young Men's Clinic (YMC) and project STAY, and staff from justice programs collaborated to increase access to care. RESULTS: We highlight the characteristics of successful partnerships drawn from the literature on community-based participatory research. CONCLUSION: We conclude with a discussion of some challenges we encountered and lessons we learned about establishing and sustaining partnerships with court, probation, parole, reentry, and diversion programs while educating the next generation of public health leaders.


Subject(s)
Academic Medical Centers , Community-Based Participatory Research , Community-Institutional Relations , Health Services Accessibility , Prisoners , Adult , Humans , Male , New York City
15.
Reprod Toxicol ; 23(4): 513-20, 2007 Jun.
Article in English | MEDLINE | ID: mdl-17367990

ABSTRACT

The trophoblast cell line, JEG-3, was used to study the cytotoxicity of phenanthrene, 9,10-phenanthrenequinone (PHEQ), anthracene, and 9,10-anthracenedione alone and with copper. The endpoints were the capacity of cultures to reduce alamar Blue (AB), a measure of energy metabolism, and to convert carboxyfluorescein diacetate acetoxymethyl ester (CFDA AM) to carboxyfluorescein, an indication of membrane integrity. Only PHEQ elicited a cytotoxic response. PHEQ caused a concentration-dependent decline in AB but not in CFDA AM readings, suggesting an impairment to energy metabolism. In the presence of copper, PHEQ concentration-response curves were shifted to the left for AB and were obtained with CFDA AM. The Cu/PHEQ synergy is attributed to an increase in redox cycling and production of reactive oxygen species (ROS), which overwhelm antioxidant defenses, damaging energy metabolism first and then membrane integrity. The impermeable copper chelator, bathocuproine, reduced the PHEQ/copper interaction, but the permeable chelator, neocuproine, and copper together were cytotoxic.


Subject(s)
Copper/toxicity , Environmental Pollutants/toxicity , Oxidative Stress/drug effects , Phenanthrenes/toxicity , Placenta/drug effects , Trophoblasts/drug effects , Anthracenes/toxicity , Anthraquinones/toxicity , Cell Line, Tumor , Cell Survival/drug effects , Chelating Agents/toxicity , Dose-Response Relationship, Drug , Drug Synergism , Energy Metabolism/drug effects , Humans , Oxidation-Reduction , Phenanthrolines/toxicity , Placenta/metabolism , Placenta/pathology , Reactive Oxygen Species/metabolism , Trophoblasts/metabolism , Trophoblasts/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...